おかえりなさい
Click “ログイン” to agree to Cointime’s 利用規約 and acknowledge that Cointime’s プライバシーポリシー applies to you.
アカウント登録
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">利用規約</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">プライバシーポリシー</a> applies to you.
siteでログインする
siteで登録する
あなたのメールアドレス
受信トレイを確認する
Click the link we sent to to sign in.
Click the link we sent to to sign up.
BioAxone Therapeutic
company
About
BioAxone Therapeutic is neuroscience company focused on the development and commercialization of technologies that target Rho signaling.
- 11 - 50
Details
- Last Funding Type
- Series B
- Last Funding Money Raised
- $12.15M
- Industries
- Biotechnology,Health Care,Therapeutics
- Founded date
- Jan 1, 2000
- Number Of Employee
- 11 - 50
- Operating Status
- Active
BioAxone Therapeutic operates as a neuroscience company. The company specializes in the development and commercialization of proprietary technologies that target Rho signaling. It provides an experimental therapy for the treatment of neurological disorders. The company's product includes Cethrin for clinical trial for spinal cord injury. BioAxone Therapeutic was founded in 2000 and is based in Saint-Laurent, Canada.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
$12.15M
BioAxone Therapeutic has raised a total of
$12.15M
in funding over 2 rounds. Their latest funding was raised on
May 20, 2005 from a Series B round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| May 20, 2005 | Series B | $12.15M | 1 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
1
BioAxone Therapeutic is funded by 1 investors.
T2C2 Capital
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
T2C2 Capital
|
— | Series B |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
